
90% of cancer patients die of cancer metastasis, especially patients with malignant cancers such as lung cancer, liver cancer, colon cancer, and rectal cancer. Cancer treatment is difficult, and most cancers have survival time less than five years. Some patients survived and treated the cancer, but they metastasized and recurred after two or three years, seriously threatening the patient's life!
Cancer metastasis be cured?

cancer new drug Y101D is a recombinant anti-PD-L1 and TGF-β bispecific antibody injection, which can simultaneously target PD-L1 and TGF-β bifunctional fusion protein (transformation growth factor-β).
Mechanistically, Y101D promotes the formation of "hot tumors": increase the number of tumor-infiltrating lymphocytes and dendritic cells , increase the proportion of M1/M2, and enhance the production of cytokines in T cells . This standardized tumor immune microenvironment and enhanced anti-tumor immune response may contribute to the powerful anti-tumor effect of Y101D.
Cancer patients have metastases or are in a downturn in treatment of cancer. You can learn about new cancer drugs and get cured opportunities through cancer clinical practice. Cancer clinical treatment is performed in regular Grade A hospitals. Patients can be more safe and reliable!

new drug clinically is Henan Province Cancer Hospital, Zhejiang Province Cancer Hospital , Sun Yat-sen University Treatment and Prevention Center!
Cancer treatment is rigorous, and patients need to meet the following situations!
- patients older than 18 years old men and women do not limit
- female patients cannot be pregnant
- patients have a strong desire to survive, and can take care of themselves during treatment
- patients' families agree to cancer clinical etc.